SS-31 (Elamipretide) 10 mg research peptide — wholesale

For research use only · Not for human consumption · Not for veterinary use. This product is supplied for in-vitro research, analytical method development, and laboratory reference standard use only. Not approved for human or veterinary administration. Buyer is responsible for end-use classification in the destination jurisdiction.

Overview

SS-31, also referenced by its International Nonproprietary Name Elamipretide, is a synthetic four-amino-acid mitochondria-targeted tetrapeptide research compound. The sequence is D-Arg-Dmt-Lys-Phe-NH2, with a 2,6-dimethyltyrosine (Dmt) residue at position 2 and an amidated C-terminus. The alternating cationic / aromatic residues confer selectivity for cardiolipin, the inner mitochondrial membrane phospholipid, and the compound is supplied for in-vitro mitochondrial membrane research, cardiolipin-binding studies, and analytical method development. SPK Pharma India supplies SS-31 10 mg as a documented, lot-traceable research compound for distributors, contract manufacturers, and academic laboratories. The disambiguation between SS-31 and Elamipretide is purely a naming convention — both refer to the same compound, with SS-31 being the laboratory designation and Elamipretide being the INN.

Specifications

Research context

SS-31 is studied in cell-based research on mitochondrial membrane biology, on the interaction of the peptide with cardiolipin, and on the downstream effects of cardiolipin stabilisation on electron transport chain function and reactive oxygen species production in defined cell-based systems. The cardiolipin-binding profile is the central research variable, and is the basis for in-vitro assays in isolated mitochondrial preparations, in cell-based mitochondrial membrane potential assays, and in analytical method development for LC-MS quantification of the peptide.

The 10 mg vial format is the standard research format, suitable for method development, mitochondrial-binding assays, and reference-standard qualification. The companion 50 mg bulk-pack format is documented on the SS-31 50 mg page. SPK Pharma India does not make therapeutic, clinical, diagnostic, or dosing claims for this product. The compound is supplied strictly for in-vitro research, analytical method development, and reference-standard work.

For researchers new to the compound, the standard analytical reference points are CAS 736992-21-5, the four-amino-acid sequence D-Arg-Dmt-Lys-Phe-NH2, the calculated molecular weight of 639.79 g/mol, the lyophilized powder form, and the documented purity threshold (≥99% HPLC).

Packaging and supply

• 10 mg research vial — the standard 10 mg research format, suitable for method development, mitochondrial-binding assays, and reference-standard qualification. Standard MOQ: 5 vials.
• Bulk pack — on application, for annual supply contracts and recurring orders.

Distributor pricing is available on application. Annual supply contracts with scheduled recurring dispatch are available for repeat buyers. Lead time for in-stock SKUs is typically 5 business days from purchase order confirmation; lead time for scheduled production is typically 4 to 6 weeks.

Quality and documentation

Every lot of SS-31 10 mg ships with a lot-matched Certificate of Analysis documenting identity (mass spectrometry and amino acid analysis), purity (HPLC), appearance, lot number, and synthesis batch reference. A representative sample of every lot is independently verified by a third-party analytical laboratory before release. MSDS is supplied with every shipment. The COA template, the lot-traceability workflow, and the third-party verification scope are documented on the Quality page.

Storage and handling

• Store at -20°C in the original sealed container.
• Protect from light and moisture.
• Allow the sealed container to reach room temperature before opening, to avoid condensation.
• Reconstitute in sterile, low-endotoxin research-grade water or in a mild buffer at the working concentration required by the assay.
• Do not refreeze once reconstituted; aliquot and store at working concentration.
• For short peptides, gentle mixing is sufficient; avoid vigorous vortexing.

Shipping

SS-31 10 mg is shipped lyophilized in sealed vials within temperature-validated packaging. International lanes are routed through dedicated life-science logistics partners with cold-chain handling. Standard dispatch is within 5 business days of purchase order confirmation. SPK Pharma India ships to the United States, the European Union, the United Kingdom, Canada, MENA, APAC, and LATAM. Full export documentation, including commercial invoice, packing list, certificate of origin, COA, and MSDS, is included with every shipment. Destination-specific documentation is supported on request.

Compliance

This product is supplied for research use only. It is not a drug, not a finished dosage form, and not approved for human or veterinary administration. SPK Pharma India does not make therapeutic, clinical, diagnostic, or dosing claims for this product. The buyer is responsible for end-use classification in the destination jurisdiction and for ensuring that downstream handling is consistent with research-use-only protocols.

Lead form CTA

To request a wholesale quote for SS-31 (Elamipretide) 10 mg, contact the trade desk with the subject line "SS-31 10 mg wholesale quote" and your company details, expected volume, and destination country. Distributor pricing is available on application. The desk responds within one business day.

Related compounds

• SS-31 50 mg — bulk-pack 50 mg research vial
• MOTS-C 20 mg — mitochondrial-derived research peptide
• MOTS-C 40 mg — bulk-pack mitochondrial-derived research peptide
• NAD+ — research-grade bulk reference standard
• FOXO4-DRI — 46-amino-acid D-retro-inverso research peptide